QOF · 2026/27
QOF — Quality & Outcomes Framework 2026/27
Last update
1 October 2026
Data source
Clinical system
Refresh
Weekly · live
Next refresh
Auto · weekly
KPIs on target
1/36
35 below · 4 monitoring
Performance
56.9%
34 payment KPIs
Highest performing
VI004
85.8% · target 50–60% · +25.8%
470 / 548
Lowest performing
CHOL003
19.5% · target 70–95% · -75.5%
1,551 / 7,950
Most improved
—
Needs 2+ uploads
On target (1)Near target (7)Below target (26)No data (6)Mon= Monitoring only — no payment threshold
| Indicator⇅ | Target⇅ | Target activity⇅ | Performance %⇅ | Activity⇅ | Population⇅ | Shortfall⇅ | Status | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory | ||||||||||||
| AST007Asthma with review in last 12 months▸ | 45–70% | 9,770 | 47.6% | 6,641 | 13,957 | 3,129 | Below | |||||
| AST012Asthma with objective tests recorded▸ | 45–80% | 802 | 68.1% | 682 | 1,002 | 120 | Near | |||||
| COPD010COPD with review including exacerbations, breathlessness▸ | 50–90% | 3,200 | 41.9% | 1,490 | 3,555 | 1,710 | Below | |||||
| Cardiovascular | ||||||||||||
| AF006Patients with AF and CHA2DS2-VASc score▸ | 40–95% | 788 | 71.4% | 592 | 829 | 196 | Below | |||||
| AF008Patients with AF and a CHA2DS2-VASc score>=2 on DOAC /Vit K antagonist▸ | 70–95% | 1,558 | 29.6% | 485 | 1,639 | 1,073 | Below | |||||
| BP002Patients aged 45 or over and blood pressure recorded▸ | 50–90% | 85,628 | 88.4% | 84,096 | 95,142 | 1,532 | Near | |||||
| CHD005CHD taking anti-platelet or anti-coagulant▸ | 56–96% | 5,933 | 88.7% | 5,482 | 6,180 | 451 | Near | |||||
| CHOL003Patients with CHD / PAD / TIA / CKD on statin/lipid-lowering therapy▸ | 70–95% | 7,553 | 19.5% | 1,551 | 7,950 | 6,002 | Below | |||||
| CHOL004Patients with LDL cholesterol <=2.0 or non-HDL <=2.6▸ | 20–50% | 4,255 | 39.9% | 3,398 | 8,510 | 857 | Below | |||||
| HF007Heart failure with review of functional capacity, medication▸ | 50–90% | 1,594 | 23.9% | 423 | 1,771 | 1,171 | Below | |||||
| HF008Heart failure diagnosis from 1 April 2023 with ECHO or specialist assess▸ | 50–90% | 711 | 82.8% | 654 | 790 | 57 | Near | |||||
| HF009HF patients on ACE-I/ARB/ARNI, beta-blocker, MRA and SGLT2 inhibitor FYMon▸ | Monitoring | — | 12.9% | 39 | 302 | — | Monitoring | |||||
| HYP008Hypertension aged 79 or under BP 140/90 mmHg or less▸ | 40–85% | 20,214 | 55.9% | 14,671 | 26,251 | 5,543 | Below | |||||
| HYP009Hypertension aged 80 or over BP 150/90 mmHg or less▸ | 40–85% | 1,674 | 58.7% | 1,229 | 2,092 | 445 | Below | |||||
| STIA007Non-haemorrhagic stroke or TIA taking anti-platelet or anti-coagulant▸ | 57–97% | 1,733 | 87.1% | 1,556 | 1,786 | 177 | Near | |||||
| Dementia | ||||||||||||
| DEM004Dementia and review done▸ | 35–70% | 756 | 28% | 302 | 1,079 | 454 | Below | |||||
| Mental Health | ||||||||||||
| MH002Mental health and care plan documented▸ | 40–90% | 3,853 | 34.2% | 1,462 | 4,281 | 2,391 | Below | |||||
| MH003Mental health problems and BP recorded in the preceding 12 months▸ | 50–90% | 4,003 | 59.6% | 2,649 | 4,447 | 1,354 | Below | |||||
| MH006Mental health problems and BMI recorded in the preceding 12 months▸ | 50–90% | 3,979 | 55.9% | 2,471 | 4,421 | 1,508 | Below | |||||
| MH007Mental health problems and alcohol recorded in last 12 months▸ | 50–90% | 3,991 | 54.1% | 2,397 | 4,434 | 1,594 | Below | |||||
| MH011Mental health problems and lipids recorded in last 12 months▸ | 50–90% | 3,981 | 56.2% | 2,484 | 4,423 | 1,497 | Below | |||||
| MH012Mental health problems and glucose/Hba1c recorded in last 12 months▸ | NIS | — | — | 1,638 | — | — | No data | |||||
| Diabetes | ||||||||||||
| DM006Diabetes and proteinuria or micro-albuminuria taking ACE-I or ARB▸ | 57–97% | 2,692 | 30.3% | 840 | 2,775 | 1,852 | Below | |||||
| DM014Newly diagnosed with diabetes referred to structured education programme▸ | 40–90% | 712 | 65.1% | 515 | 791 | 197 | Below | |||||
| DM020Diabetes no moderate/severe frailty IFCC-HbA1c is 58 mmol/mol or less▸ | 35–75% | 15,973 | 40.2% | 8,563 | 21,297 | 7,410 | Below | |||||
| DM021Diabetes with frailty IFCC-HbA1c is 75 mmol/mol or less▸ | NIS | — | — | 1,543 | — | — | No data | |||||
| DM034Diabetes aged >=40 no CVD/frailty on statin or lipid-lowering therapy▸ | 50–90% | 10,904 | 20.3% | 2,456 | 12,115 | 8,448 | Below | |||||
| DM035Diabetes with CVD (not haemorrhagic) on statin or lipid-lowering therapy▸ | 50–90% | 5,652 | 40.2% | 2,522 | 6,279 | 3,130 | Below | |||||
| DM036Diabetes no moderate/severe frailty BP 140/90 mmHg or less▸ | 38–90% | 20,316 | 65% | 13,606 | 20,944 | 6,710 | Below | |||||
| DM037Diabetes with care processes performed in last 12 months FYMon▸ | Monitoring | — | 47.1% | 11,352 | 24,117 | — | Monitoring | |||||
| Vaccination & Immunisation | ||||||||||||
| VI001Three or more DTaP vaccine doses before 8 months▸ | 89–96% | 3,817 | 66.8% | 2,654 | 3,976 | 1,163 | Below | |||||
| VI002One or more MMR doses aged 12-18 months▸ | 86–96% | 3,805 | 67.4% | 2,670 | 3,963 | 1,135 | Below | |||||
| VI003Aged 1-5 years with DTaP/IPV booster and at least 2 doses of MMR▸ | 81–96% | 3,408 | 70.2% | 2,492 | 3,549 | 916 | Below | |||||
| VI004Aged 80 with shingles vaccine received between 70-79 years▸ | 50–60% | 329 | 85.8% | 470 | 548 | Met | Met | |||||
| Cervical Screening | ||||||||||||
| CS005Aged 25-49 adequate smear last 3 years and 6 months▸ | 45–80% | 66,004 | 54.8% | 45,252 | 82,504 | 20,752 | Below | |||||
| CS006Aged 50-64 adequate smear last 5 years and 6 months▸ | 45–80% | 14,100 | 77.6% | 13,672 | 17,625 | 428 | Near | |||||
| Smoking | ||||||||||||
| SMOK002Chronic disease and smoking status recorded▸ | 50–90% | 53,756 | 86% | 51,374 | 59,728 | 2,382 | Near | |||||
| SMOK004Current smokers with an offer of support given▸ | 40–90% | 41,837 | 73.6% | 34,231 | 46,485 | 7,606 | Below | |||||
| Obesity | ||||||||||||
| OB004Patients age >=18 with obesity referred to weight management FYMon▸ | Monitoring | — | — | 2,222 | — | — | Monitoring | |||||
| OB005Patients NICE TA1026 cohort,shared decision,meds,behavioural referral FYMon▸ | Monitoring | — | — | 7 | — | — | Monitoring | |||||
Data as of 1 October 2026 · Clinical system · Refreshed weekly